SEND NEWS ARTICLE TO FRIEND
To Email:
From Email:
News Headline
EnVivo Pharmaceuticals, Inc. Announces Initiation of Phase 2 Clinical Trial Program of EVP-0962 in Alzheimer’s Disease
Your Message